KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Net Margin (2016 - 2026)

Medtronic (MDT) has disclosed Net Margin for 13 consecutive years, with 12.75% as the latest value for Q1 2026.

  • Quarterly Net Margin fell 296.0% to 12.75% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 13.08% through Jan 2026, up 17.0% year-over-year, with the annual reading at 13.99% for FY2025, 255.0% up from the prior year.
  • Net Margin hit 12.75% in Q1 2026 for Medtronic, down from 15.42% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 19.1% in Q1 2022 to a low of 5.75% in Q4 2022.
  • Historically, Net Margin has averaged 13.42% across 5 years, with a median of 13.24% in 2024.
  • Biggest five-year swings in Net Margin: plummeted -1104bps in 2022 and later soared 566bps in 2023.
  • Year by year, Net Margin stood at 5.75% in 2022, then soared by 99bps to 11.41% in 2023, then soared by 33bps to 15.21% in 2024, then grew by 1bps to 15.42% in 2025, then dropped by -17bps to 12.75% in 2026.
  • Business Quant data shows Net Margin for MDT at 12.75% in Q1 2026, 15.42% in Q4 2025, and 12.21% in Q3 2025.